Comparison of Clinical Characteristics and Treatment Outcome Between Localized and Disseminated Nocardiosis in a Tertiary Hospital in China
DOI: https://doi.org/10.2147/idr.s458124
2024-06-15
Infection and Drug Resistance
Abstract:Li Zhang, 1, &ast Menglan Zhou, 2, 3, &ast Ziran Wang, 2, 3, &ast Hongqiong Zhu, 4 Jing Lin, 1, 5 Minya Lu, 2, 3 Ying Ge, 1 Yingchun Xu, 2, 3 Taisheng Li, 1 Zhengyin Liu 1 1 Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, People's Republic of China; 2 Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 3 Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Peking Union Medical College Hospital, Beijing, People's Republic of China; 4 Department of Infectious Disease, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, People's Republic of China; 5 Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhengyin Liu, Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Number 1, Shuaifuyuan Road, Dongcheng District, Beijing, People's Republic of China, Email Background: In China, due to the large population, infections caused by Nocardia may not be as rare. Unfortunately, there is still inadequate knowledge of the clinical impact caused by Nocardia. This study aimed to compare the clinical characteristics and treatment of localized and disseminated nocardiosis. Methods: The clinical and microbiological data of patients diagnosed with nocardiosis in a tertiary hospital in Beijing from July 2011 to July 2021 were collected and retrospectively analyzed. Results: Among the 54 nocardiosis cases, 34 cases were in the localized infection group, while 20 cases in the disseminated infection group. The proportion of patients with chronic structural lung disease was higher in the localized group ( P =0.010). In contrast, patients with disseminated infections were more prone to receive long-term glucocorticoids and/or immunosuppressants ( P =0.027). Pulmonary nodules were prominent features of imaging changes in patients with disseminated infections ( P =0.027) whereas bronchial dilatation was more common in patients with localized infections ( P =0.025). In addition, the disseminated group had longer average hospitalization days relative to the localized group ( P =0.016), but there was no significant difference in mortality between them ( P =0.942). Conclusion: There were differences in the clinical profiles between patients with localized and disseminated nocardiosis in terms of clinical presentation, infection site, radiological features, treatment, and prognosis. These findings may provide references for the management and treatment of patients with nocardiosis. Keywords: Nocardia , disseminated nocardiosis, immunosuppressive population Nocardia is a Gram-positive aerobic bacterium characterized by hyphae-like branching. It is a common pathogen in the environment, often found in soil, decomposing vegetation and other organic matter, as well as in fresh and salt water. 1 So far, more than 100 of species of Nocardia have been identified, among which over 40 species have been shown to be clinically relevant. 2 Notably, Nocardia is often regarded as an "opportunistic infection agent" and most infections usually occur in immunosuppressed individuals under chemotherapy, organ transplants or with immunodeficiency diseases. Nocardia was first reported in 1988, and it was reported that the annual incidence of Nocardia infection/colonization increased from 0.33 (1997–1998) to 0.87 (2007–2008) per 100,000 inhabitants in Quebec, Canada. 3 Pulmonary nocardiosis is the most common type of infection, and the main symptoms are fever, cough, shortness of breath, weight loss and night sweats. Additionally, extrapulmonary nocardiosis is also relatively common and can spread to the pleura, pericardium, mediastinum, and vena cava through hematogenous dissemination or continuous spread of necrotizing pneumonia. Disseminated nocardiosis may lead to the involvement of diverse systems, such as the central nervous system (CNS), soft tissue, blood, and lymph nodes. 4 The mortality rate for nocardiosis ranges from 7% to 44%, but is further increased in cases of disseminated ba -Abstract Truncated-
pharmacology & pharmacy,infectious diseases